A dual GIP and GLP-1 receptor agonist — a synthetic peptide that mimics two gut hormones involved in blood sugar and appetite regulation.
TRIZ3P is a high-quality research compound designed for laboratory and research applications. It is produced with strict quality standards to ensure purity, consistency, and reliable performance for research professionals.
$95.00
A dual GIP and GLP-1 receptor agonist — a synthetic peptide that mimics two gut hormones involved in blood sugar and appetite regulation.
Developed and FDA-approved for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound).
Reduced appetite, slowed gastric emptying, improved blood sugar control, and significant weight loss in clinical trials.
FDA-approved prescription medication when dispensed as the brand product. Compounded (non-brand) versions exist but face increasing FDA scrutiny now that the official shortage has ended; sourcing and purity vary widely outside licensed pharmacies.
